Impact of Non-pharmaceutical Interventions Targeted at COVID-19 Pandemic on Influenza Burden - a Systematic Review

Overview

Journal J Infect

Specialty Infectious Diseases

Date 2020 Dec 5

PMID 33278399

Citations 76

Authors

Lara Marleen Fricke

Stephan Glockner

Maren Dreier

Berit Lange

Affiliations

Soon will be listed here.

Abstract

Objectives: To better understand the impact of comprehensive COVID-19 targeted non-pharmaceutical interventions (NPIs) on influenza burden worldwide.

Methods: We conducted a systematic literature search in selected databases (PubMed, WHO COVID-19), preprint servers (medRxiv, bioRxiv) and websites of European Public Health institutes. Documents that compared influenza estimates in the 2019/2020 season with previous seasons were included. Information synthesis was qualitative due to a high heterogeneity in the number and periods of comparative seasons, outcome measures and statistical methods.

Results: We included 23 records reporting from 15 countries/regions as well as 8 reports from European Public Health agencies. Estimates in the 2019/2020 season based on influenza virus tests (4 out of 7 countries/regions), defined influenza cases (8 out of 9), influenza positivity rate (7 out of 8), and severe complications (1 out of 2) were lower than in former seasons. Results from syndromic indicators, such as influenza-like-illness (ILI), were less clear or even raised (4 out of 7) after the influenza season indicating a misclassification with COVID-19 cases.

Conclusions: Evidence synthesis suggests that NPIs targeted at SARS-CoV-2-transmission reduce influenza burden as well. Low threshold NPIs need to be more strongly emphasized in influenza prevention strategies.

Citing Articles

Lower Airway Diseases in the Paediatric Population: A Two-Year, Single-Centre, Retrospective Study.

Ferrero A, Versace A, Denina M, Spagna G, Fera A, Conrieri M J Clin Med. 2025; 14(2).

PMID: 39860390 PMC: 11766243. DOI: 10.3390/jcm14020384.

Trend of pathogens and respiratory co-infections in the province of Messina: from pediatric age to senescence.

Genovese C, Gorgone M, Genovese G, La Spada G, Balsamo D, Calderone S J Prev Med Hyg. 2025; 65(3):E344-E355.

PMID: 39758766 PMC: 11698104. DOI: 10.15167/2421-4248/jpmh2024.65.3.3344.

The prevalence of in children in Shandong, China before, during, and after COVID-19.

Kong W, Wang Q, Zhuo J, Zhuang X Front Pediatr. 2024; 12:1479311.

PMID: 39722766 PMC: 11668564. DOI: 10.3389/fped.2024.1479311.

Influence of the Enterovirus 71 Vaccine and the COVID-19 Pandemic on Hand, Foot, and Mouth Disease in China Based on Counterfactual Models: Observational Study.

Nie J, Huang T, Sun Y, Peng Z, Dong W, Chen J JMIR Public Health Surveill. 2024; 10:e63146.

PMID: 39692430 PMC: 11683655. DOI: 10.2196/63146.

Coxsackievirus A6 U.K. Genetic and Clinical Epidemiology Pre- and Post-SARS-CoV-2 Emergence.

Joyce A, Hill J, Tsoleridis T, Astbury S, Berry L, Howson-Wells H Pathogens. 2024; 13(11).

PMID: 39599573 PMC: 11597771. DOI: 10.3390/pathogens13111020.

References

Wiese A, Everson J, Grijalva C . Social Distancing Measures: Evidence of Interruption of Seasonal Influenza Activity and Early Lessons of the SARS-CoV-2 Pandemic. Clin Infect Dis. 2020; 73(1):e141-e143. PMC: 7337694. DOI: 10.1093/cid/ciaa834. View

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

Cowling B, Ali S, Ng T, Tsang T, Li J, Fong M . Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health. 2020; 5(5):e279-e288. PMC: 7164922. DOI: 10.1016/S2468-2667(20)30090-6. View

Wiemken T, Shacham E . Identifying potential undocumented COVID-19 using publicly reported influenza-like-illness and laboratory-confirmed influenza disease in the United States: An approach to syndromic surveillance?. Am J Infect Control. 2020; 48(8):961-963. PMC: 7211575. DOI: 10.1016/j.ajic.2020.05.007. View

Flaxman S, Mishra S, Gandy A, Unwin H, Mellan T, Coupland H . Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020; 584(7820):257-261. DOI: 10.1038/s41586-020-2405-7. View

Wolfel R, Corman V, Guggemos W, Seilmaier M, Zange S, Muller M . Virological assessment of hospitalized patients with COVID-2019. Nature. 2020; 581(7809):465-469. DOI: 10.1038/s41586-020-2196-x. View

Hsieh C, Lin C, Wang W, Pauleen D, Chen J . The Outcome and Implications of Public Precautionary Measures in Taiwan-Declining Respiratory Disease Cases in the COVID-19 Pandemic. Int J Environ Res Public Health. 2020; 17(13). PMC: 7370162. DOI: 10.3390/ijerph17134877. View

Choe Y, Lee J . The Impact of Social Distancing on the Transmission of Influenza Virus, South Korea, 2020. Osong Public Health Res Perspect. 2020; 11(3):91-92. PMC: 7258883. DOI: 10.24171/j.phrp.2020.11.3.07. View

Yang C, Chen T, Kuo S, Hsieh M, Chen Y . Severe complicated influenza declined during the prevention of COVID-19 in Taiwan. Infect Control Hosp Epidemiol. 2020; 42(4):499-501. PMC: 7287302. DOI: 10.1017/ice.2020.272. View

10.

Wu D, Lu J, Liu Y, Zhang Z, Luo L . Positive effects of COVID-19 control measures on influenza prevention. Int J Infect Dis. 2020; 95:345-346. PMC: 7151395. DOI: 10.1016/j.ijid.2020.04.009. View

11.

Noh J, Seong H, Yoon J, Song J, Cheong H, Kim W . Social Distancing against COVID-19: Implication for the Control of Influenza. J Korean Med Sci. 2020; 35(19):e182. PMC: 7234863. DOI: 10.3346/jkms.2020.35.e182. View

12.

Wilson N, Norton A, Young F, Collins D . Airborne transmission of severe acute respiratory syndrome coronavirus-2 to healthcare workers: a narrative review. Anaesthesia. 2020; 75(8):1086-1095. PMC: 7264768. DOI: 10.1111/anae.15093. View

13.

Mateus A, Otete H, Beck C, Dolan G, Nguyen-Van-Tam J . Effectiveness of travel restrictions in the rapid containment of human influenza: a systematic review. Bull World Health Organ. 2015; 92(12):868-880D. PMC: 4264390. DOI: 10.2471/BLT.14.135590. View

14.

Simonsen L, Spreeuwenberg P, Lustig R, Taylor R, Fleming D, Kroneman M . Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study. PLoS Med. 2013; 10(11):e1001558. PMC: 3841239. DOI: 10.1371/journal.pmed.1001558. View

15.

Lee H, Lee H, Song K, Kim E, Park J, Jung J . Impact of Public Health Interventions on Seasonal Influenza Activity During the COVID-19 Outbreak in Korea. Clin Infect Dis. 2020; 73(1):e132-e140. PMC: 7314207. DOI: 10.1093/cid/ciaa672. View

16.

Jackson C, Vynnycky E, Hawker J, Olowokure B, Mangtani P . School closures and influenza: systematic review of epidemiological studies. BMJ Open. 2013; 3(2). PMC: 3586057. DOI: 10.1136/bmjopen-2012-002149. View

17.

Soo R, Chiew C, Ma S, Pung R, Lee V . Decreased Influenza Incidence under COVID-19 Control Measures, Singapore. Emerg Infect Dis. 2020; 26(8):1933-1935. PMC: 7392467. DOI: 10.3201/eid2608.201229. View

18.

Kuo S, Shih S, Chien L, Hsiung C . Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan. Emerg Infect Dis. 2020; 26(8):1928-1930. PMC: 7392415. DOI: 10.3201/eid2608.201192. View

19.

Sun J, Shi Z, Xu H . Non-pharmaceutical interventions used for COVID-19 had a major impact on reducing influenza in China in 2020. J Travel Med. 2020; 27(8). PMC: 7188119. DOI: 10.1093/jtm/taaa064. View

20.

Itaya T, Furuse Y, Jindai K . Does COVID-19 infection impact on the trend of seasonal influenza infection? 11 countries and regions, from 2014 to 2020. Int J Infect Dis. 2020; 97:78-80. PMC: 7261472. DOI: 10.1016/j.ijid.2020.05.088. View